19 April 2018 - Deborah Wilkes
Premium
Teva Pharmaceutical says it will continue to build its OTC business after the company's PGT Healthcare OTC joint venture with Procter & Gamble ends on 1 July 2018.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.